Literature DB >> 5016292

Cutaneous responses to cholera skin toxin in man. I. Responses in unimmunized American males.

J P Craig, E R Eichner, R B Hornick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5016292     DOI： 10.1093/infdis/125.3.203

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  12 in total

1.  Antigenicity of purified glutaraldehyde-treated cholera toxoid administered orally.

Authors:  M M Levine; T P Hughes; C R Young; S O'Donnell; J P Craig; H P Holley; E J Bergquist
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

2.  Short communications. Subunit A from cholera toxin is an activator of adenylate cyclase in pigeon erythrocytes.

Authors:  S Van Heyningen; C A King
Journal:  Biochem J       Date:  1975-01       Impact factor: 3.857

Review 3.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1973-05       Impact factor: 2.401

4.  Protection against colibacillosis in neonatal piglets by immunization of dams with procholeragenoid.

Authors:  E Fürer; S J Cryz; F Dorner; J Nicolet; M Wanner; R Germanier
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

5.  Development of a purified cholera toxoid. II. Preparation of a stable, antigenic toxoid by reaction of purified toxin with glutaraldehyde.

Authors:  R S Rappaport; G Bonde; T McCann; B A Rubin; H Tint
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

6.  Preparation of a purified antigenic cholera toxoid.

Authors:  R Germanier; E Fürer; S Varallyay; T M Inderbitzin
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

7.  Isolation of skin permeability factors from culture filtrates of Salmonella typhimurium.

Authors:  P D Sandefur; J W Peterson
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

8.  Protection against challenge with Escherichia coli heat-labile enterotoxin by immunization of rats with cholera toxin/toxoid.

Authors:  N F Pierce
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

9.  Development of a purified cholera toxoid. I. Purification of toxin.

Authors:  R S Rappaport; B A Rubin; H Tint
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

10.  Microtiter enzyme-linked immunosorbent assay for immunoglobulin g cholera antitoxin in humans: sensitivity and specificity.

Authors:  R M Robins-Browne; C R Young; M M Levine; J P Craig
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.